These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments. Alstrup M; Meyer J; Schultz M; Rasmussen LJH; Rasmussen LS; Køber L; Forberg JL; Eugen-Olsen J; Iversen K World J Surg; 2019 Mar; 43(3):780-790. PubMed ID: 30390135 [TBL] [Abstract][Full Text] [Related]
15. Soluble urokinase plasminogen activator receptor as a long-term prognostic biomarker in acute coronary syndromes. Peiró ÓM; Cediel G; Bonet G; Rojas S; Quintern V; Carrasquer A; González-Del-Hoyo M; Sanz E; Bardají A Biomarkers; 2020 Jul; 25(5):402-409. PubMed ID: 32551985 [No Abstract] [Full Text] [Related]
16. SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease. Hodges G; Lyngbæk S; Selmer C; Ahlehoff O; Theilade S; Sehestedt TB; Abildgaard U; Eugen-Olsen J; Galløe AM; Hansen PR; Jeppesen JL; Bang CN Scand Cardiovasc J; 2020 Dec; 54(6):339-345. PubMed ID: 32400206 [TBL] [Abstract][Full Text] [Related]
17. Induction of interleukin-19 and interleukin-22 after cardiac surgery with cardiopulmonary bypass. Hsing CH; Hsieh MY; Chen WY; Cheung So E; Cheng BC; Chang MS Ann Thorac Surg; 2006 Jun; 81(6):2196-201. PubMed ID: 16731153 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome. Chenevier-Gobeaux C; Lemarechal H; Doumenc B; Peschanski N; Claessens YE; Borderie D; Ray P Clin Biochem; 2021 Jun; 92():19-24. PubMed ID: 33662350 [TBL] [Abstract][Full Text] [Related]
19. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. TAMAYO E; ALVAREZ FJ; ALONSO O; BUSTAMANTE R; CASTRODEZA J; SORIA S; LAJO C J Cardiovasc Surg (Torino); 2009 Oct; 50(5):687-94. PubMed ID: 19741581 [TBL] [Abstract][Full Text] [Related]
20. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function. Nikorowitsch J; Borchardt T; Appelbaum S; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M J Am Heart Assoc; 2020 Apr; 9(8):e015452. PubMed ID: 32299288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]